The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling ...

This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...

On Tuesday, Secretary of Defense Pete Hegseth announced that the men and women who defend our nation will be able to choose ...

Federal regulators are proposing a new, faster Medicare coverage pathway for medical devices deemed by the FDA as ...

WASHINGTON — President Trump heralded a drug pricing agreement with Regeneron on Thursday, closing the last of 17 deals ...

From my colleague Andrew Joseph: One of the open questions about the future of Sanofi as Belén Garijo takes over as CEO this ...

The constant pressure that the heart is under from beating thousands of times a day may create an environment hostile to ...

After inviting consumers to upload medical records for examination by ChatGPT earlier this year, OpenAI is now making its ...

Kennedy, a lawsuit challenging Kennedy’s attempts to remake the Advisory Committee on Immunization Practices. For the moment, ...

Legislators in two states have resisted efforts to restrict Prescription Drug Affordability Boards, the controversial panels that are designed to function as rate-setting authorities and place limits ...

The promise of a better pan-RAS inhibitor Erasca has been described as the poor man’s Revolution Medicines. Impoverished ...

As links between pharmaceutical companies and telehealth providers grow, health policy experts and legislators have sounded ...